The Competition Tribunal is set to reopen an investigation into the pricing practices of pharmaceutical giant GlaxoSmithKline, after announcing that it had agreed to hear the AIDS Healthcare Foundation's (AHF's) complaint against the company over its AIDS drugs prices. Glaxo is the world's largest manufacturer of AIDS drugs, with patents on three of the most widely used antiretroviral medicines